Cephalon Settles FCA Suit Over Provigil Marketing
Cephalon Inc. has settled a whistleblower's False Claims Act suit over the company's alleged off-label promotion of its narcolepsy drug Provigil, according to an order filed in Pennsylvania federal court Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article